| Identification | |
| Name: | Hydrazine,1,2-diethyl-, hydrochloride (1:2) |
| Synonyms: | Hydrazine,1,2-diethyl-, dihydrochloride (6CI,9CI); 1,2-Diethylhydrazine dihydrochloride;N,N'-Diethylhydrazine dihydrochloride |
| CAS: | 7699-31-2 |
| Molecular Formula: | C4H12 N2 . 2 Cl H |
| Molecular Weight: | 161.07336 |
| InChI: | InChI=1S/C4H12N2.2ClH/c1-3-5-6-4-2;;/h5-6H,3-4H2,1-2H3;2*1H |
| Molecular Structure: |  |
| Properties | |
| Transport: | 2811 |
| Specification: | usageEng:Reactant involved in:• ;Bromopyridazinedione-mediated protein and peptide bioconjugation1• ;Synthesis of human neutrophil proteinase 3 inhibitors2• ;Three-component cascade processes for sythesis of aminoisoindolones and phthalazones3• ;Stereoselective heterocyclization for synthesis of substituted hexahydropyrazolodiazepinecarboxylates4• ;Synthesis of azacycloalkanes, isoindoles, pyrazole, pyrazolidine, and phthalazine derivatives5 Safety Statements:53-26-36/37/39-45 53:Avoid exposure - obtain special instruction before use 26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice 36/37/39:Wear suitable protective clothing, gloves and eye/face protection 45:In case of accident or if you feel unwell, seek medical advice immediately (show label where possible) |
| Packinggroup: | III |
| Usage: | Reactant involved in:• ;Bromopyridazinedione-mediated protein and peptide bioconjugation1• ;Synthesis of human neutrophil proteinase 3 inhibitors2• ;Three-component cascade processes for sythesis of aminoisoindolones and phthalazones3• ;Stereoselective heterocyclization for synthesis of substituted hexahydropyrazolodiazepinecarboxylates4• ;Synthesis of azacycloalkanes, isoindoles, pyrazole, pyrazolidine, and phthalazine derivatives5 |
| Safety Data | |
| Hazard Symbols |
T: Toxic
|
 |
|
